PinCell

Acquired

Innovation in dermatology

Italy · $1.8M raised

Employees
1–10
Business Model
B2B
Website
pincell.it
Total Funding
$1.8M
Last Round
$1.8M SeedMay 2021
Rounds
1

About

PinCell is a pre-clinical stage biotechnology company based in Italy focused on the development of novel anti-inflammatory therapies for rare and severe dermatological diseases with high unmet medical need. The company targets novel pathological pathways to develop first-in-class treatments for orphan skin diseases, leveraging the expertise of co-founder and CMO Professor Carlo Pincelli.

Summary

PinCell is a Biotech company based in Italy. It has raised $1.8M in total across 1 round, most recently a $1.8M Seed round in May 2021. Investors include Sofinnova Partners.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

AcquisitionMar 2025

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies